ROS-responsive magnesium-containing microspheres for antioxidative treatment of intervertebral disc degeneration. (1st March 2023)

• Record Type: Journal Article
• Authors: Zhang, Tianhui; Wang, Yongjie; Li, Ruhui; Xin, Jingguo; Zheng, Zhi; Zhang, Xingmin; Xiao, Chunsheng; Zhang, Shaokun
• Is Part Of: Acta biomaterialia. Volume 158(2023)
• Page Start: 475
• Page End: 492
• Publication Date: 2023-03-01
• Subjects: Reactive oxygen species -- Antioxidant therapy -- Magnesium -- Hydrogen -- Intervertebral disc degeneration; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2023.01.020
• Languages: English
• ISSNs: 1742-7061

Abstract

Abstract: Intervertebral disc degeneration (IVDD) is a degenerative disease characterized by lower-back pain, causing disability globally. Antioxidant therapy is currently considered one of the most promising strategies for IVDD treatment, given the crucial role of reactive oxygen species (ROS) in IVDD pathogenesis. Herein, a ROS-responsive magnesium-containing microsphere (Mg@PLPE MS) was constructed for the antioxidative treatment of IVDD. The Mg@PLPE MS has a core-shell structure comprising poly(lactic- co -glycolic acid) (PLGA) and ROS-responsive polymer poly(PBT- co -EGDM) as the shell and a magnesium microparticle as the core. The poly(PBT- co -EGDM) can be destroyed by H2 O2 through the H2 O2 -triggered hydrophobic-to-hydrophilic transition, subsequently promoting an Mg-water reaction to produce H2 . Thus, Mg@PLPE MS provides a valuable platform for H2 O2 elimination and controlled H2 release. The generated H2 scavenge for ROS by reacting with noxious OH. Notably, the Mg@PLPE MS exerted significant antioxidative and anti-inflammatory effects in a disc degeneration rat model and alleviated extracellular matrix degradation and disc cells apoptosis, thereby underlining its efficacy in IVDD treatment. The Mg@PLPE MS also exhibited robust biocompatibility and negligible toxicity, presenting the promise for the antioxidative treatment of IVDD in vivo . Statement of significance: Antioxidant therapy is currently considered one of the most promising strategies for intervertebral disc degeneration (IVDD) treatment, given the crucial role of reactive oxygen species (ROS) in IVDD pathogenesis. Here, ROS-responsive magnesium-containing microspheres (Mg@PLPE MSs) were constructed to alleviate IVDD through controlled release of hydrogen gas. The Mg@PLPE MSs can effectively scavenge overproduced ROS by simultaneously reacting with H2 O2 and OH, thus creating a suitable microenvironment for inhibition of ECM degradation. As a result, Mg@PLPE MSs treated IVDD rats exhibit minimal nucleus pulposus decrease, less extracellular matrix degradation, minimal radial fissure of fibrous rings, and higher disc height index. Therefore, the as-prepared Mg@PLPE MSs may shed a new light on clinical treatment of IVDD. Graphical abstract: Image, graphical abstract